Akero Therapeutics

Youtube Subscribe

Open: 22.11 Close: 23.57 Change: 1.46

Is Akero Therapeutics Company Inc a good investment? This what an AI found.

This document will help you to evaluate Akero Therapeutics without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Akero Therapeutics are: Akero, Therapeutics, Inc, NASDAQAKRO, target, price, defense, …

Concept Map

Semantic Network

Stock Summary

Akero Therapeutics, Inc. engages in the development of transformational treatments for patients with serious metabolic diseases. The company was formerly known as Pippin Pharmaceuticals, Inc..

Today's Summary

Akero Therapeutics, Inc. (NASDAQ:AKRO) target price at $40.86 - defense world.com. Brokerages Set Akero therapeuticutics, inc. (nasdaq:akro) Target Price at $39.86. Akero Therapeutics shares plunge on liver disease treatments mixed results. Akeros experimental NASH drug meets the primary endpoint in a clinical trial.

Today's News

Akero Therapeutics, Inc. (NASDAQ:AKRO) target price at $40.86 - defense world.com. Brokerages Set Akero therapeuticutics, inc. (nasdaq:akro) Target Price at $39.86. Akero Therapeutics shares plunge on liver disease treatments mixed results. Akeros experimental NASH drug meets the primary endpoint in a clinical trial.

Stock Profile

"Akero Therapeutics, Inc., a clinical-stage company, engages in the development of transformational treatments for patients with serious metabolic diseases, including non-alcoholic steatohepatitis (NASH), a disease without any approved therapies. Its lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regulates metabolism of lipids, carbohydrates, and proteins throughout the body. The company is also conducting a Phase 2b clinical trial to evaluate EFX in the treatment of biopsy-confirmed NASH patients. The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California."

Keywords

The game is changing. There is a new strategy to evaluate Akero Therapeutics fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Akero Therapeutics are: Akero, Therapeutics, Inc, NASDAQAKRO, target, price, defense, and the most common words in the summary are: therapeutic, inc, pharmaceutical, pharma, bioscience, biopharma, ltd, . One of the sentences in the summary was: Brokerages Set Akero therapeuticutics, inc. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #therapeutic #inc #pharmaceutical #pharma #bioscience #biopharma #ltd.

Read more →

Youtube Subscribe

---